Sukenari Koyabu

514 citations
15 papers · 184 indexed · h-index 7
Topics
Cancer, Lipids, and Metabolism (4 papers)Blood Pressure and Hypertension Studies (4 papers)Cholesterol and Lipid Metabolism (3 papers)
Partner nations
Japan

In The Last Decade

Sukenari Koyabu

15 papers receiving 181 citations

Peers

Sukenari Koyabu
Comparison fields: 5 of 49
  • Cardiology and Cardiovascular Medicine 76
  • Surgery 56
  • Molecular Biology 38
  • Endocrinology, Diabetes and Metabolism 37
  • Pulmonary and Respiratory Medicine 31
Replace Hua Meng with:
Hua Meng China
Fernando Bugatto Spain
Aiyun Song China
R. R. Overman United States
Elisavet Vasilopoulou United Kingdom
Zhendi Wang China
Jianxia Fan China
Alberto García-Hernández Netherlands
Xiaojuan Jiao China
Sukenari Koyabu relative to Hua Meng China Hua Meng's profile →
Citations per field
00.5×1.6×
Hua Meng · 1×
Citations per year

Countries citing papers authored by Sukenari Koyabu

Since Specialization
Citations

This map shows the geographic impact of Sukenari Koyabu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sukenari Koyabu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sukenari Koyabu more than expected).

Fields of papers citing papers by Sukenari Koyabu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sukenari Koyabu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sukenari Koyabu. The network helps show where Sukenari Koyabu may publish in the future.

Co-authorship network of co-authors of Sukenari Koyabu

This figure shows the co-authorship network connecting the top 25 collaborators of Sukenari Koyabu. A scholar is included among the top collaborators of Sukenari Koyabu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sukenari Koyabu. Sukenari Koyabu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
#WorkIndexed citations
1 2
2 8
3 1
4 5
5 1
6 35
7 9
8 19
9 5
10 1
11 2
12 2
13 27
14 42
15 25

About Sukenari Koyabu

Sukenari Koyabu is a scholar working on Endocrinology, Diabetes and Metabolism, Cardiology and Cardiovascular Medicine and Nephrology, having authored 15 papers that have together received 184 indexed citations. Recurring topics across this work include Cancer, Lipids, and Metabolism (4 papers), Blood Pressure and Hypertension Studies (4 papers) and Cholesterol and Lipid Metabolism (3 papers). The work is most often cited by research in Cardiology and Cardiovascular Medicine (76 citations), Environmental Chemistry (31 citations) and Nephrology (18 citations). Sukenari Koyabu has collaborated with scholars based in Japan. Frequent co-authors include Takeshi Nakano, Kan Katayama, T Murata, Hideaki Ishikawa, Tetsuya Seko, Takahiro Nakano, Shinsuke Nomura, Takashi Yada, Naoki Isaka and Tokuji Konishi. Their work appears in journals such as Kidney International, CHEST Journal and American Heart Journal.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026